Your Search
Sort Options
Search results
Pages
![Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma](/sites/all/modules/custom/islandora_solr_search/images/defaultimg.png?solr_nav%5Bid%5D=7fe6874a5a6ac31a914e&solr_nav%5Bpage%5D=0&solr_nav%5Boffset%5D=2)
- •This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing non-oncogene-addicted mNSCLC.
- •ESMO-MCBS scores are given to describe the levels of evidence for...
- •This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing non-oncogene-addicted mNSCLC.
- •ESMO-MCBS scores are given to describe the levels of evidence for treatment choices.
- •ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.
- •Recommendations are based on available scientific data and the authors’ collective expert opinion.
- •In clinical practice, all recommendations provided need to be discussed with patients in a shared decision-making approach.
![Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients](/sites/all/modules/custom/islandora_solr_search/images/defaultimg.png?solr_nav%5Bid%5D=7fe6874a5a6ac31a914e&solr_nav%5Bpage%5D=0&solr_nav%5Boffset%5D=17)
![Time Trends in Treatment Strategies and Survival of Older versus Younger Patients with Synchronous Metastasised Melanoma-A Population-Based Study in the Netherlands Cancer Registry](/sites/all/modules/custom/islandora_solr_search/images/defaultimg.png?solr_nav%5Bid%5D=7fe6874a5a6ac31a914e&solr_nav%5Bpage%5D=0&solr_nav%5Boffset%5D=19)